...
首页> 外文期刊>Pathology and Laboratory Medicine International >Sensitization with atypical mycobacteria is a potent risk factor for cross-reaction with the delayed type hypersensitivity assay in mice
【24h】

Sensitization with atypical mycobacteria is a potent risk factor for cross-reaction with the delayed type hypersensitivity assay in mice

机译:非典型分枝杆菌致敏是与延迟型超敏反应测定在小鼠中发生交叉反应的有效危险因素

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Abstract: Tuberculosis is a disease that infects approximately two billion people worldwide. The current diagnostic test utilizes purified protein derivative (PPD) obtained from Mycobacterium tuberculosis cultures to elicit a host delayed type hypersensitivity reaction to identify infected individuals. This reaction is manifested as an induration at 48 hours following intradermal i-njection. These experiments demonstrate that in a mouse model, repeated administrations of PPD do not elicit a positive tuberculin skin test (TST). However, prior sensitization to -environmental mycobacteria does induce a positive TST when administered via the intraperitoneal or oral route. This work has important implications regarding the specificity of the PPD reagent, disease diagnosis, and environmental mycobacteria.
机译:摘要:结核病是一种感染全球约20亿人口的疾病。当前的诊断测试利用从结核分枝杆菌培养物中获得的纯化蛋白衍生物(PPD)引发宿主迟发型超敏反应,以鉴定感染的个体。皮内注射后48小时,该反应表现为硬结。这些实验证明,在小鼠模型中,PPD的重复给药不会引起结核菌素皮肤试验(TST)阳性。然而,当通过腹膜内或口服途径给药时,先前对环境分枝杆菌的致敏作用确实会引起TST阳性。这项工作对PPD试​​剂的特异性,疾病诊断和环境分枝杆菌具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号